Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma

RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome

Li, B., & Dewey, C. N. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-323 · Cited by 22,179

Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.

Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849

Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma

Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113205 · Cited by 7,774

Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1

Verhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.020 · Cited by 7,575

Identification of human brain tumour initiating cells

Singh, S. K., Hawkins, C. E., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,564

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,517

An Integrated Genomic Analysis of Human Glioblastoma Multiforme

Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857

The Somatic Genomic Landscape of Glioblastoma

Brennan, C. W., Verhaak, R. G. W., McKenna, A., Campos, B., Noushmehr, H., Salama, S. R., Zheng, S., Chakravarty, D., Sanborn, J. Z., Berman, S. H., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.034 · Cited by 5,016

A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function

Cahoy, J. D., Emery, B., Kaushal, A., Foo, L. C., Zamanian, J. L., Christopherson, K. S., Xing, Y., Lubischer, J. L., Krieg, P. A., Krupenko, S. A., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4178-07.2008 · Cited by 3,129

Single-Cell Analyses Reveal Mechanisms of Cancer Stem Cell Maintenance and Epithelial–Mesenchymal Transition in Recurrent Bladder Cancer

Wang, H., Mei, Y., Luo, C., Huang, Q., Wang, Z., Lu, G.-M., Qin, L., Sun, Z., Huang, C.-W., Yang, Z.-W., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-4796 · Cited by 116

Clonal hematopoiesis

Jan, M., Ebert, B. L., & Jaiswal, S. (2016) · Seminars in Hematology · doi:10.1053/j.seminhematol.2016.10.002 · Cited by 119

Review of single-cell RNA-seq data clustering for cell-type identification and characterization

Zhang, S., Li, X., Lin, J., Lin, Q., & Wong, K. (2023) · RNA · doi:10.1261/rna.078965.121 · Cited by 120

EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation

Eskilsson, E., Røsland, G. V., Talasila, K. M., Knappskog, S., Keunen, O., Sottoriva, A., Foerster, S., Solecki, G. M., Taxt, T., Jiřík, R., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now113 · Cited by 115

Apoptotic Signaling Pathways in Glioblastoma and Therapeutic Implications

Valdés-Rives, S. A., Casique‐Aguirre, D., German‐Castelan, L., Velasco-Velázquez, M. A., & González‐Arenas, A. (2017) · BioMed Research International · doi:10.1155/2017/7403747 · Cited by 117

Neuroblastoma pathogenesis: deregulation of embryonic neural crest development

Tomolonis, J., Agarwal, S., & Shohet, J. M. (2017) · Cell and Tissue Research · doi:10.1007/s00441-017-2747-0 · Cited by 122

NF1 regulates mesenchymal glioblastoma plasticity and aggressiveness through the AP-1 transcription factor FOSL1

Marques, C., Unterkircher, T., Kroon, P., Oldrini, B., Izzo, A., Dramaretska, Y., Ferrarese, R., Kling, E., Schnell, O., Nelander, S., et al. (2021) · eLife · doi:10.7554/elife.64846 · Cited by 117

Neoadjuvant PARPi or chemotherapy in ovarian cancer informs targeting effector Treg cells for homologous-recombination-deficient tumors

Luo, Y., Xia, Y., Liu, D., Li, X., Li, H., Liu, J., Zhou, D., Dong, Y. J., Li, X., Qian, Y., et al. (2024) · Cell · doi:10.1016/j.cell.2024.06.013 · Cited by 120

Single cell transcriptome analysis of mouse carotid body glomus cells

Zhou, T., Chien, M., Kaleem, S., & Matsunami, H. (2016) · The Journal of Physiology · doi:10.1113/jp271936 · Cited by 113

Multimodal imaging patterns predict survival in recurrent glioblastoma patients treated with bevacizumab

Chang, K., Zhang, B., Guo, X., Zong, M., Rahman, R. M., Sanchez, D. A., Winder, N. M., Reardon, D. A., Zhao, B., Wen, P. Y., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now086 · Cited by 114

Efficient Generation of Transcriptomic Profiles by Random Composite Measurements

Cleary, B., Cong, L., Cheung, A., Lander, E. S., & Regev, A. (2017) · Cell · doi:10.1016/j.cell.2017.10.023 · Cited by 114

XYZeq: Spatially resolved single-cell RNA sequencing reveals expression heterogeneity in the tumor microenvironment

Lee, Y., Bogdanoff, D., Wang, Y., Hartoularos, G. C., Woo, J. M., Mowery, C. T., Nisonoff, H. M., Lee, D. S., Sun, Y., Lee, J., et al. (2021) · Science Advances · doi:10.1126/sciadv.abg4755 · Cited by 110

Single‐cell RNA sequencing reveals tumor heterogeneity, microenvironment, and drug‐resistance mechanisms of recurrent glioblastoma

Wu, H., Guo, C., Wang, C., Xu, J., Zheng, S., Duan, J., Li, Y., Bai, H., Xu, Q., Ning, F., et al. (2023) · Cancer Science · doi:10.1111/cas.15773 · Cited by 116

Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature‐on‐a‐Chip System Correlates with Tumor Heterogeneity and Subtypes

Xiao, Y., Kim, D., Dura, B., Zhang, K., Yan, R., Li, H., Han, E., Ip, J., Zou, P., Liu, J., et al. (2019) · Advanced Science · doi:10.1002/advs.201801531 · Cited by 115

Comprehensive molecular characterization of multifocal glioblastoma proves its monoclonal origin and reveals novel insights into clonal evolution and heterogeneity of glioblastomas

Abou‐El‐Ardat, K., Seifert, M., Becker, K., Eisenreich, S., Lehmann, M., Hackmann, K., Rump, A., Meijer, G. A., Carvalho, B. G., Temme, A., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now231 · Cited by 114

Interest of integrins targeting in glioblastoma according to tumor heterogeneity and cancer stem cell paradigm: an update

Malric, L., Monferran, S., Gilhodes, J., Boyrie, S., Dahan, P., Skuli, N., Sesen, J., Filleron, T., Kowalski‐Chauvel, A., Moyal, E. C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20372 · Cited by 115

Identification of a distinct luminal subgroup diagnosing and stratifying early stage prostate cancer by tissue-based single-cell RNA sequencing

Ma, X., Guo, J., Liu, K., Chen, L., Liu, D., Dong, S., Xia, J., Long, Q., Yue, Y., Zhao, P., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01264-9 · Cited by 116

Distinct regional ontogeny and activation of tumor associated macrophages in human glioblastoma

Landry, A., Balas, M., Alli, S. B., Spears, J., & Zador, Z. E. (2020) · Scientific Reports · doi:10.1038/s41598-020-76657-3 · Cited by 114

Dissecting the single-cell transcriptome network underlying esophagus non-malignant tissues and esophageal squamous cell carcinoma

Chen, Z., Zhao, M., Liang, J., Hu, Z., Huang, Y., Li, M., Pang, Y., Lu, T., Sui, Q., Zhan, C., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103459 · Cited by 111

Tumor Heterogeneity—A ‘Contemporary Concept’ Founded on Historical Insights and Predictions

Welch, D. R. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3024 · Cited by 116

p120-catenin-dependent collective brain infiltration by glioma cell networks

Gritsenko, P. G., Atlasy, N., Dieteren, C. E. J., Navis, A. C., Venhuizen, J.-H., Veelken, C., Schubert, D., Acker-Palmer, A., Westerman, B. A., Wurdinger, T., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-019-0443-x · Cited by 112

The Progress of Multi-Omics Technologies: Determining Function in Lactic Acid Bacteria Using a Systems Level Approach

O’Donnell, S. T., Ross, R. P., & Stanton, C. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.03084 · Cited by 118

Integrative Single-Cell Analysis Reveals Transcriptional and Epigenetic Regulatory Features of Clear Cell Renal Cell Carcinoma

Yu, Z., Lv, Y., Su, C., Lu, W., Zhang, R., Li, J., Guo, B., Yan, H., Liu, D., Yang, Z., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-2224 · Cited by 116

Wnt and Notch signaling govern self-renewal and differentiation in a subset of human glioblastoma stem cellsPreprint

Rajakulendran, N., Rowland, K., Selvadurai, H. J., Ahmadi, M., Park, N. I., Naumenko, S., Dolma, S., Ward, R. J., So, M., Lee, L., et al. (2019) · Genes & Development · doi:10.1101/gad.321968.118 · Cited by 115

Biological activity of tumor-treating fields in preclinical glioma models

Silginer, M., Weller, M., Stupp, R., & Roth, P. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.171 · Cited by 111

Comprehensive analysis of PD-L1 expression in glioblastoma multiforme

Heiland, D. H., Haaker, G., Delev, D., Mercas, B., Masalha, W., Heynckes, S., Gaebelein, A., Pfeifer, D., Carro, M. S., Weyerbrock, A., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15031 · Cited by 113

Circulating Tumor Cells as a Tool for Assessing Tumor Heterogeneity

Tellez-Gabriel, M., Heymann, M., & Heymann, D. (2019) · Theranostics · doi:10.7150/thno.34337 · Cited by 112

Establishment of age group classification for risk stratification in glioma patients

Lin, Z., Yang, R., Li, K., Yi, G., Li, Z., Guo, J., Zhang, Z., Junxiang, P., Liu, Y., Qi, S., et al. (2020) · BMC Neurology · doi:10.1186/s12883-020-01888-w · Cited by 114

Transcriptomics and solid tumors: The next frontier in precision cancer medicine

Tsimberidou, A. M., Fountzilas, E., Bleris, L. G., & Kurzrock, R. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.09.007 · Cited by 118

Targeting cathepsin B by cycloastragenol enhances antitumor immunity of CD8 T cells via inhibiting MHC-I degradation

Deng, G., Zhou, L., Wang, B., Sun, X., Zhang, Q., Chen, H., Wan, N., Ye, H., Wu, X., Sun, D., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-004874 · Cited by 114

Culture conditions defining glioblastoma cells behavior: what is the impact for novel discoveries?

Ledur, P. F., Onzi, G. R., Zong, H., & Lenz, G. (2017) · Oncotarget · doi:10.18632/oncotarget.20193 · Cited by 106

Multiregional radiomics profiling from multiparametric MRI: Identifying an imaging predictor of IDH1 mutation status in glioblastoma

Li, Z., Bai, H., Sun, Q., Zhao, Y., Lv, Y., Zhou, J. H., Liang, C., Chen, Y., Liang, D., & Zheng, H. (2018) · Cancer Medicine · doi:10.1002/cam4.1863 · Cited by 112

Fast and accurate single-cell RNA-seq analysis by clustering of transcript-compatibility counts

Ntranos, V., Kamath, G. M., Zhang, J. M., Pachter, L. S., & Tse, D. N. C. (2016) · Genome biology · doi:10.1186/s13059-016-0970-8 · Cited by 110

Spectrum: fast density-aware spectral clustering for single and multi-omic data

John, C. R., Watson, D., Barnes, M. R., Pitzalis, C., & Lewis, M. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz704 · Cited by 114

Locally secreted BiTEs complement CAR T cells by enhancing killing of antigen heterogeneous solid tumors

Yin, Y., Rodriguez, J. L., Li, N., Thokala, R., Nasrallah, M. P., Hu, L., Zhang, L., Zhang, J. V., Logun, M. T., Kainth, D., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.05.011 · Cited by 110

Spatiotemporal analysis of glioma heterogeneity reveals COL1A1 as an actionable target to disrupt tumor progression

Comba, A., Faisal, S. M., Dunn, P., Argento, A. E., Hollon, T. C., Al‐Holou, W. N., Varela, M. L., Zamler, D. B., Quass, G. L., Apostolides, P. F., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31340-1 · Cited by 123

Molecular cartography uncovers evolutionary and microenvironmental dynamics in sporadic colorectal tumors

Heiser, C. N., Simmons, A. J., Revetta, F. L., McKinley, E. T., Ramirez-Solano, M. A., Wang, J., Kaur, H., Shao, J., Ayers, G. D., Wang, Y., et al. (2023) · Cell · doi:10.1016/j.cell.2023.11.006 · Cited by 112

Integrated proteogenomic characterization of glioblastoma evolution

Kim, K., Migliozzi, S., Koo, H., Hong, J.-H., Park, S. M., Kim, S., Kwon, H. J., Ha, S., Garofano, L., Oh, Y. T., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2023.12.015 · Cited by 123

Droplet-based single cell RNAseq tools: a practical guide

Salomon, R., Kaczorowski, D., Valdes-Mora, F., Nordon, R. E., Neild, A., Farbehi, N., Bartonicek, N., & Gallego-Ortega, D. (2019) · Lab on a Chip · doi:10.1039/c8lc01239c · Cited by 109

Immunotherapy for Glioblastoma: Adoptive T-cell Strategies

Choi, B. D., Maus, M. V., June, C. H., & Sampson, J. H. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1625 · Cited by 113

Glioblastoma Immune Landscape and the Potential of New Immunotherapies

Daubon, T., Hémadou, A., Garmendia, I. R., & Saleh, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.585616 · Cited by 111

Spatially organized tumor-stroma boundary determines the efficacy of immunotherapy in colorectal cancer patients

Feng, Y., Ma, W., Zang, Y., Guo, Y., Li, Y., Zhang, Y., Dong, X., Liu, Y., Zhan, X., Pan, Z., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54710-3 · Cited by 128

NF-κB and STAT3 in glioblastoma: therapeutic targets coming of age

Gray, G. K., McFarland, B. C., Nozell, S. E., & Benveniste, E. N. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.964211 · Cited by 109

Single-Cell Transcriptional Analysis

Wu, A. R., Wang, J., Streets, A., & Huang, Y. (2017) · Annual Review of Analytical Chemistry · doi:10.1146/annurev-anchem-061516-045228 · Cited by 107

GPD1 Specifically Marks Dormant Glioma Stem Cells with a Distinct Metabolic Profile

Rusu, P., Shao, C., Neuerburg, A., Acikgöz, A. A., Wu, Y., Zou, P., Phapale, P., Shankar, T. S., Döring, K., Dettling, S., et al. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.06.004 · Cited by 108

Cell Lineage-Based Stratification for Glioblastoma

Wang, Z., Sun, D., Chen, Y.-J., Xie, X., Shi, Y., Tabar, V. S., Brennan, C., Bale, T., Jayewickreme, C. D., Laks, D. R., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.06.003 · Cited by 106

The Stress-Like Cancer Cell State Is a Consistent Component of Tumorigenesis

Baron, M., Tagore, M. M., Hunter, M. V., Kim, I. S., Moncada, R. M., Yan, Y., Campbell, N. R., White, R. M., & Yanai, I. (2020) · Cell Systems · doi:10.1016/j.cels.2020.08.018 · Cited by 104

Systematic analysis of somatic mutations impacting gene expression in 12 tumour types

Ding, J., McConechy, M. K., Horlings, H. M., Ha, G., Chan, F. C., Funnell, T., Mullaly, S. C., Reimand, J., Bashashati, A., Bader, G. D., et al. (2015) · Nature Communications · doi:10.1038/ncomms9554 · Cited by 108

The potential of single-cell profiling in plants

Efroni, I., & Birnbaum, K. D. (2016) · Genome biology · doi:10.1186/s13059-016-0931-2 · Cited by 107

De novo gene signature identification from single‐cell RNA‐seq with hierarchical Poisson factorization

Levitin, H. M., Yuan, J., Cheng, Y. L., Ruiz, F. J. R., Bush, E. C., Bruce, J. N., Canoll, P., Iavarone, A., Lasorella, A., Blei, D. M., et al. (2019) · Molecular Systems Biology · doi:10.15252/msb.20188557 · Cited by 98

Potential biomarkers and challenges in glioma diagnosis, therapy and prognosis

Kan, L. K., Drummond, K. J., Hunn, M., Williams, D. J., O'Brien, T. J., & Monif, M. (2020) · BMJ Neurology Open · doi:10.1136/bmjno-2020-000069 · Cited by 109

ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma

Arrieta, V. A., Chen, A., KANE, J. R., Kang, S. J., Kassab, C., Dmello, C., Zhao, J., Burdett, K. B., Upadhyayula, P. S., Lee-Chang, C., et al. (2021) · Nature Cancer · doi:10.1038/s43018-021-00260-2 · Cited by 108

CAR T Cell Therapy in Glioblastoma: Overcoming Challenges Related to Antigen Expression

Luksik, A. S., Yazigi, E., Shah, P. P., & Jackson, C. M. (2023) · Cancers · doi:10.3390/cancers15051414 · Cited by 113

THBS2 + cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K/AKT activation in colorectal cancer

Zhou, X., Han, J., Zuo, A., Ba, Y., Liu, S., Xu, H., Zhang, Y., Weng, S., Zhou, Z., Liu, L., et al. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02180-y · Cited by 113

Inertial-ordering-assisted droplet microfluidics for high-throughput single-cell RNA-sequencing

Moon, H., Je, K., Min, J.-W., Park, D., Han, K., Shin, S., Park, W., Yoo, C. E., & Kim, S. (2018) · Lab on a Chip · doi:10.1039/c7lc01284e · Cited by 107

Astrocytes enhance glioblastoma growth

Mega, A., Nilsen, M. H., Leiss, L. W., Tobin, N. P., Miletić, H., Sleire, L., Strell, C., Nelander, S., Krona, C. C., Hägerstrand, D., et al. (2019) · Glia · doi:10.1002/glia.23718 · Cited by 106

Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells

Stangeland, B., Mughal, A. A., Grieg, Z., Sandberg, C. J., Joel, M., Nygård, S., Meling, T. R., Murrell, W. G., Vik-Mo, E. O., & Langmoen, I. A. (2015) · Oncotarget · doi:10.18632/oncotarget.4613 · Cited by 110

An epigenetic gateway to brain tumor cell identity

Mack, S. C., Hubert, C. G., Miller, T. E., Taylor, M. D., & Rich, J. N. (2015) · Nature Neuroscience · doi:10.1038/nn.4190 · Cited by 106

Resistance to mTORC1 Inhibitors in Cancer Therapy: From Kinase Mutations to Intratumoral Heterogeneity of Kinase Activity

Faes, S., Demartines, N., & Dormond, O. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/1726078 · Cited by 104

Functional Ultrasound (fUS) During Awake Brain Surgery: The Clinical Potential of Intra-Operative Functional and Vascular Brain Mapping

Soloukey, S., Vincent, A. J. P. E., Satoer, D., Mastik, F., Smits, M., Dirven, C. M. F., Strydis, C., Bosch, J. G., van der Steen, A. F. W., Zeeuw, C. I. D., et al. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01384 · Cited by 105

An algorithm to quantify intratumor heterogeneity based on alterations of gene expression profiles

Li, M., Zhang, Z., Li, L., & Wang, X. (2020) · Communications Biology · doi:10.1038/s42003-020-01230-7 · Cited by 100

The glucose ketone index calculator: a simple tool to monitor therapeutic efficacy for metabolic management of brain cancer

Meidenbauer, J. J., Mukherjee, P., & Seyfried, T. N. (2015) · Nutrition & Metabolism · doi:10.1186/s12986-015-0009-2 · Cited by 105

Utility of Glioblastoma Patient-Derived Orthotopic Xenografts in Drug Discovery and Personalized Therapy

Patrizii, M., Bartucci, M., Pine, S. R., & Sabaawy, H. E. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00023 · Cited by 107

Multi‐Dimensional Organic Mass Cytometry: Simultaneous Analysis of Proteins and Metabolites on Single Cells

Xu, S., Liu, M., Bai, Y., & Liu, H. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202009682 · Cited by 104

CARM1 Inhibition Enables Immunotherapy of Resistant Tumors by Dual Action on Tumor Cells and T Cells

Kumar, S., Zeng, Z., Bagati, A., Tay, R. E., Sanz, L. A., Hartono, S. R., Ito, Y., Abderazzaq, F. O., Hatchi, E., Jiang, P., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1144 · Cited by 106

Reactive oxygen species produced by altered tumor metabolism impacts cancer stem cell maintenance

Tuy, K., Rickenbacker, L., & Hjelmeland, A. B. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101953 · Cited by 107

Unravelling tumour heterogeneity—implications for therapy

Reardon, D. A., & Wen, P. Y. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.223 · Cited by 106

The convergent roles of the nuclear factor I transcription factors in development and cancer

Chen, K., Lim, J. W. C., Richards, L. J., & Bunt, J. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.09.015 · Cited by 102

scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapy

Ocasio, J. K., Babcock, B. R., Malawsky, D. S., Weir, S., Loo, L., Simon, J. M., Zylka, M. J., Hwang, D., Dismuke, T., Sokolsky‐Papkov, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13657-6 · Cited by 99

Integrated single-cell transcriptomic analyses reveal that GPNMB-high macrophages promote PN-MES transition and impede T cell activation in GBM

Xiong, A., Zhang, J., Chen, Y., Zhang, Y., & Yang, F. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104239 · Cited by 103

Single-cell sequencing of ascites fluid illustrates heterogeneity and therapy-induced evolution during gastric cancer peritoneal metastasis

Huang, X., Pang, M.-J., Li, J.-Y., Chen, H., Sun, J., Song, Y., Ni, H.-J., Ye, S.-Y., Bai, S., Li, T., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36310-9 · Cited by 115

Transcriptional and Translational Heterogeneity among Neonatal Mouse Spermatogonia1

Hermann, B. P., Mutoji, K. N., Velte, E. K., Ko, D., Oatley, J. M., Geyer, C. B., & McCarrey, J. R. (2015) · Biology of Reproduction · doi:10.1095/biolreprod.114.125757 · Cited by 104

Extracellular vesicles in the biology of brain tumour stem cells – Implications for inter-cellular communication, therapy and biomarker development

Nakano, I., Garnier, D., Minata, M., & Rak, J. W. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.02.011 · Cited by 106

Translational control of aberrant stress responses as a hallmark of cancer

El-Naggar, A. M., & Sorensen, P. H. B. (2018) · The Journal of Pathology · doi:10.1002/path.5030 · Cited by 105

Molecular pathway activation – New type of biomarkers for tumor morphology and personalized selection of target drugs

Buzdin, A. A., Sorokin, M., Garazha, A., Sekacheva, M. I., Kim, E. L., Zhukov, N. V., Wang, Y., Li, X., Kar, S., Hartmann, C. J., et al. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.06.003 · Cited by 103

New tools for pathology: a user's review of a highly multiplexed method for in situ analysis of protein and RNA expression in tissue

Decalf, J., Albert, M. L., & Ziai, J. M. (2018) · The Journal of Pathology · doi:10.1002/path.5223 · Cited by 105

Identifying and removing the cell-cycle effect from single-cell RNA-Sequencing data

Barron, M., & Li, J. (2016) · Scientific Reports · doi:10.1038/srep33892 · Cited by 105

Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities

Oh, S., Yeom, J., Cho, H. J., Kim, J.-H., Yoon, S., Kim, H.-D., Sa, J. K., Ju, S., Lee, H., Oh, M. J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17139-y · Cited by 100

Single-cell RNA sequencing reveals intratumoral heterogeneity in primary uveal melanomas and identifies HES6 as a driver of the metastatic disease

Pandiani, C., Strub, T., Nottet, N., Chéli, Y., Gambi, G., Bille, K., Husser, C., Dalmasso, M., Béranger, G. E., Lassalle, S., et al. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-020-00730-7 · Cited by 103

The white matter is a pro-differentiative niche for glioblastoma

Brooks, L. J., Clements, M., Burden, J. J., Kocher, D., Richards, L., Devesa, S. C., Zakka, L., Woodberry, M., Ellis, M. J., Jaunmuktane, Z., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22225-w · Cited by 106

Advances in immunotherapy for glioblastoma multiforme

Mahmoud, A. B., Ajina, R., Aref, S., Darwish, M., Alsayb, M. A., Taher, M., Alsharif, S. T., Hashem, A. M., & Alkayyal, A. A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.944452 · Cited by 103

Neuronal and tumourigenic boundaries of glioblastoma plasticity

Silva, M. I. D., Stringer, B. W., & Bardy, C. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.10.010 · Cited by 110

Glioblastoma epigenome profiling identifies SOX10 as a master regulator of molecular tumour subtype

Wu, Y., Fletcher, M., Gu, Z., Wang, Q., Costa, B., Bertoni, A., Man, K.-H., Schlotter, M., Felsberg, J., Mangei, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-20225-w · Cited by 101

Coexpression analysis of CD133 and CD44 identifies Proneural and Mesenchymal subtypes of glioblastoma multiforme

Brown, D. V., Daniel, P. M., D’Abaco, G. M., Gogos, A., Ng, W., Morokoff, A. P., & Mantamadiotis, T. (2015) · Oncotarget · doi:10.18632/oncotarget.3365 · Cited by 104

Single‐cell sequencing maps gene expression to mutational phylogenies in PDGF‐ and EGF‐driven gliomas

Müller, S., Liu, S. J., Lullo, E. D., Malatesta, M., Pollen, A. A., Nowakowski, T. J., Kohanbash, G., Aghi, M. K., Kriegstein, A. R., Lim, D. A., et al. (2016) · Molecular Systems Biology · doi:10.15252/msb.20166969 · Cited by 102

Pan-cancer inference of intra-tumor heterogeneity reveals associations with different forms of genomic instability

Raynaud, F., Mina, M., Tavernari, D., & Ciriello, G. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007669 · Cited by 106

Activation of Dopamine Receptor 2 Prompts Transcriptomic and Metabolic Plasticity in Glioblastoma

Caragher, S. P., Shireman, J. M., Huang, M., Miska, J. M., Atashi, F., Baisiwala, S., Park, C. H., Saathoff, M. R., Warnke, L., Xiao, T., et al. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.1589-18.2018 · Cited by 101

Improved detection of diffuse glioma infiltration with imaging combinations: a diagnostic accuracy study

Verburg, N., Koopman, T., Yaqub, M. M., Hoekstra, O. S., Lammertsma, A. A., Barkhof, F., Pouwels, P. J. W., Reijneveld, J. C., Heimans, J. J., Rozemuller, A. J. M., et al. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz180 · Cited by 102

Tumor-promoting macrophages prevail in malignant ascites of advanced gastric cancer

Eum, H. H., Kwon, M., Ryu, D., Jo, A., Chung, W., Kim, N., Hong, Y., Son, D., Kim, S. T., Lee, J., et al. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00538-y · Cited by 104

Single-cell joint detection of chromatin occupancy and transcriptome enables higher-dimensional epigenomic reconstructions

Xiong, H., Luo, Y., Wang, Q., Yu, X., & He, A. (2021) · Nature Methods · doi:10.1038/s41592-021-01129-z · Cited by 100

Current Challenges in Glioblastoma: Intratumour Heterogeneity, Residual Disease, and Models to Predict Disease Recurrence

Ellis, H. P., Greenslade, M., Powell, B., Spiteri, I., Sottoriva, A., & Kurian, K. M. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00251 · Cited by 105

Challenges and Opportunities in Studying the Epidemiology of Ovarian Cancer Subtypes

Doherty, J. A., Peres, L. C., Wang, C., Way, G. P., Greene, C. S., & Schildkraut, J. M. (2017) · Current Epidemiology Reports · doi:10.1007/s40471-017-0115-y · Cited by 104

Effects of 3D culturing conditions on the transcriptomic profile of stem-cell-derived neurons

Tekin, H., Simmons, S., Cummings, B. B., Gao, L. A., Adiconis, X., Hession, C. C., Ghoshal, A., Dionne, D. A., Choudhury, S., Yesilyurt, V., et al. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0219-9 · Cited by 97

Importance of GFAP isoform‐specific analyses in astrocytoma

van Bodegraven, E. J., van Asperen, J. V., Robe, P. A. J. T., & Hol, E. M. (2019) · Glia · doi:10.1002/glia.23594 · Cited by 99

Synaptic input to brain tumors: clinical implications

Venkataramani, V., Tanev, D. I., Kuner, T., Wick, W., & Winkler, F. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa158 · Cited by 102

An Overview of EGFR Mechanisms and Their Implications in Targeted Therapies for Glioblastoma

Rodriguez, S. M. B., Kamel, A. E., Ciubotaru, G. V., Onose, G., Sevastre, A.-S., Sfredel, V., Dănoiu, S., Dricu, A., & Tătăranu, L. G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311110 · Cited by 108

Neuron–oligodendroglial interactions in health and malignant disease

Taylor, K. R., & Monje, M. (2023) · Nature reviews. Neuroscience · doi:10.1038/s41583-023-00744-3 · Cited by 106

Differential response of patient-derived primary glioblastoma cells to environmental stiffness

Grundy, T. J., Leon, E. D., Griffin, K. R., Stringer, B. W., Day, B. W., Fabry, B., Cooper-White, J. J., & O’Neill, G. M. (2016) · Scientific Reports · doi:10.1038/srep23353 · Cited by 99

BRIE: transcriptome-wide splicing quantification in single cells

Huang, Y., & Sanguinetti, G. (2017) · Genome biology · doi:10.1186/s13059-017-1248-5 · Cited by 103

Drug and disease signature integration identifies synergistic combinations in glioblastoma

Stathias, V., Jermakowicz, A. M., Maloof, M. E., Forlin, M., Walters, W. M., Suter, R. K., Durante, M. A., Williams, S. L., Harbour, J. W., Volmar, C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07659-z · Cited by 101

Intratumoural heterogeneity in primary glioblastoma

(2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.114

Unravelling glioblastoma heterogeneity by single-cell RNA sequencing

Yang, C., & Cheng, E. (2024) · International Conference on Biological Engineering and Medical Science (ICBioMed) · doi:10.1117/12.3013140 · Cited by 1

Deciphering brain tumor heterogeneity, one cell at a time

Qazi, M. A., Bakhshinyan, D., & Singh, S. K. (2019) · Nature Medicine · doi:10.1038/s41591-019-0605-1 · Cited by 16

Unravelling glioblastoma heterogeneity by means of single-cell RNA sequencing

Martínez, A. H., Madurga, R., Garcia‐Romero, N., & Ayuso‐Sacido, Á. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.12.008 · Cited by 95

Dissecting human gliomas by single-cell RNA sequencing

Tirosh, I., & Suvà, M. L. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox126 · Cited by 72